Tuesday, January 27, 2015 6:49:10 PM
http://www.bluebirdbio.com/about-management.php
Nick Leschly has served as our president and chief executive officer since September 2010. Previously, he served as our interim chief executive officer from March 2010 to September 2010. Formerly a partner of Third Rock Ventures, L.P. since its founding in 2007, Mr. Leschly played an integral role in the overall formation, development and business strategy of several of Third Rock's portfolio companies, including Agios Pharmaceuticals, Inc. and Edimer Pharmaceuticals, Inc. Prior to joining Third Rock, he worked at Millennium Pharmaceuticals, Inc., leading several early-stage drug development programs and served as the product and alliance leader for VELCADE. Mr. Leschly also founded and served as chief executive officer of MedXtend Corporation. He received his B.S. in molecular biology from Princeton University and his MBA. from Wharton Business School. He currently serves as a member of the Biotechnology Industry Organization board.
Recent BLUE News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/15/2024 12:00:51 PM
- bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 10/04/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:04:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:06:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:06:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:06:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:06:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:06:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:06:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/01/2024 07:10:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/01/2024 05:33:57 PM
- bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing • Business Wire • 09/27/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/27/2024 08:23:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:09:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/26/2024 08:01:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 11:03:12 AM
- bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025 • Business Wire • 09/24/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:02:05 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/16/2024 08:04:42 PM
- bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q • Business Wire • 09/13/2024 08:41:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/13/2024 08:37:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/13/2024 08:28:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:04:54 PM
- bluebird bio Announces September Investor Events • Business Wire • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:06:48 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM